Steven O Connell

Steven O Connell has a diverse work experience spanning various industries and roles. Steven is currently the Director of Operations and UK Company Director at Pear Bio, a computational biology company specializing in precision medicine. In this role, they are responsible for managing the company culture, hiring talent, and overseeing business operations. Prior to this, Steven was the Operations Lead and UK Company Director at Pear Bio.

Alongside their role at Pear Bio, Steven has also been involved in other ventures. Steven is an Investor at tbh, an honest hazelnut cocoa spread brand, and at TaxScouts, a company focused on simplifying personal tax preparation. Additionally, Steven has invested in Emitwise, a company providing carbon management solutions for businesses.

Previously, Steven worked as an Associate Director and Programme Manager at SOSV, a deeptech VC fund. Steven played an integral role in sourcing new investment opportunities and expanding operations. Steven also held the position of Assistant Director and Programme Manager at SOSV prior to their promotion.

Before joining SOSV, Steven worked as a Business Development Associate at GlowDx, a molecular diagnostics company, where they were involved in day-to-day operations and business development activities. Steven also gained experience as a Business Development Intern at Vasorum Ltd., where they contributed to the development of a business plan for a cardiovascular medical device platform.

Steven began their career as a Procurement Intern at Ervia, where they gained insight into a business environment. Steven also worked as a Process Development Technologist at MSD, where they received training in fermentation systems and lab equipment.

Overall, Steven O Connell's work experience showcases their expertise in operations management, business development, and investment.

Steven O'Connell obtained a Master's Degree in Biotechnology and Business from University College Dublin in 2015. Prior to that, they earned a Bachelor's Degree in BSc (Hons) - Pharmaceutical Biotechnology from Munster Technological University, which they completed in 2014. In terms of additional certifications, Steven O'Connell obtained "Barriers to Extreme Ownership" certification from Echelon Front in January 2023. Steven also acquired "Introduction to the Biology of Cancer - The Johns Hopkins University School of Medicine" certification from Coursera in October 2021.